Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease

Clinical trial NCT02743806 · TERMINATED

Trial details

NCT number: NCT02743806
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Colitis, Ulcerative Crohn Disease

Start date: 2016-08-01
Primary completion: 2023-01-03
Enrollment: 331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.